Evidence map›Paper›PMID 36075220›Full record

ArticleMolecular cell2022

S1-END-seq reveals DNA secondary structures in human cells.

Gabriel Matos-Rodrigues, Niek van Wietmarschen, Wei Wu, Veenu Tripathi, Natasha C Koussa, Raphael Pavani, William J Nathan, Elsa Callen, Frida Belinky, Ashraf Mohammed and 5 more

Open access · greenAbstract read
In one paragraph

Article in Molecular cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Non-canonical DNA in human and other ape telomere-to-telomere genomes.bioRxiv : the preprint server for biology · 2025
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Gabriel Matos-RodriguesLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Niek van WietmarschenLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Wei WuLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Veenu TripathiLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Natasha C KoussaLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Raphael PavaniLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
William J NathanLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Elsa CallenLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Frida BelinkyLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Ashraf MohammedDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Marek NapieralaDepartment of Neurology, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA.
Karen UsdinLaboratory of Cell and Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Aseem Z AnsariDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Sergei M MirkinDepartment of Biology, Tufts University, Medford, MA, USA. Electronic address: sergei.mirkin@tufts.edu.
André NussenzweigLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA. Electronic address: andre_nussenzweig@nih.gov.
National Human Genome Research Institute · USNational Cancer Institute · USSt. Jude Children's Research Hospital · USNational Institutes of Health · USThe University of Texas Southwestern Medical Center · USTufts University · US

Funding

NIGMS Equipment SupplementR35GM130322 · NIGMS · TUFTS UNIVERSITY MEDFORD · PI SERGEI MIRKIN · 2019 to 2026
$4.6M
GAA REPEATS INDUCED EPIGENETIC SILENCING IN FRIEDREICH'S ATAXIAR01NS081366 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI NAPIERALA, MAREK · 2012 to 2021
$3.7M
Synthetic molecules to stimulate the expression of Frataxin to ameliorate Freidreichs AtaxinR01NS108376 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI ASEEM Z ANSARI · 2018 to 2026
$3.6M
Defining the impact of Frataxin point mutations on Friedreich's ataxia pathogenesisR01NS121038 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI NAPIERALA, MAREK · 2021 to 2025
$2.0M
NIGMS NIH HHS R35 GM130322NINDS NIH HHS R01 NS081366NINDS NIH HHS R01 NS108376NINDS NIH HHS R01 NS121038
6 · The paper itself

Abstract

DNA becomes single stranded (ssDNA) during replication, transcription, and repair. Transiently formed ssDNA segments can adopt alternative conformations, including cruciforms, triplexes, and quadruplexes. To determine whether there are stable regions of ssDNA in the human genome, we utilized S1-END-seq to convert ssDNA regions to DNA double-strand breaks, which were then processed for high-throughput sequencing. This approach revealed two predominant non-B DNA structures: cruciform DNA formed by expanded (TA)

Indexed as

DNA, CruciformNylonsDNADNA Breaks, Double-StrandedDNA ReplicationHumansNucleic Acid ConformationDNADNA, CruciformNylonscruciformsDNA secondary structuresEND-seqFriederichs ataxiagenome instabilityH-DNAmutationsnon B-DNAtriplexes

Identifiers

PMID36075220
PMCPMC9547894
OpenAlexW4295014395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.